[MDXG] MiMedx Group, Inc


Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 8.86 Change: 0.14 (1.61%)
Ext. hours: Change: 0 (0%)

chart MDXG

Refresh chart

Strongest Trends Summary For MDXG

MDXG is in the medium-term up 70% in 3 months and down -50% in 6 months. In the long-term down -83% below S&P in 2 years and up 6% in 14 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company?s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company?s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force,

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 59.41% Sales Growth - Q/Q3.02% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA10.58% ROE13% ROI
Current Ratio4.46 Quick Ratio4.23 Long Term Debt/Equity Debt Ratio0.21
Gross Margin89.36% Operating Margin8.78% Net Profit Margin8.05% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-13.96 M Cash From Investing Activities-1.17 M Cash From Operating Activities7.14 M Gross Profit40.59 M
Net Profit5.43 M Operating Profit5.65 M Total Assets113.84 M Total Current Assets91.81 M
Total Current Liabilities19.46 M Total Debt Total Liabilities20.6 M Total Revenue45.68 M
Technical Data
High 52 week17.96 Low 52 week1.15 Last close2.63 Last change-0.75%
RSI61.4 Average true range0.14 Beta0.39 Volume429.19 K
Simple moving average 20 days2.64% Simple moving average 50 days17.22% Simple moving average 200 days-43.83%
Performance Data
Performance Week1.15% Performance Month28.29% Performance Quart-57.72% Performance Half-36.78%
Performance Year-83.7% Performance Year-to-date46.93% Volatility daily4.45% Volatility weekly9.95%
Volatility monthly20.39% Volatility yearly70.63% Relative Volume207.6% Average Volume4.51 M
New High New Low


2019-02-22 14:28:00 | Short-Selling Is Really Hard. Just Ask Citron Research

2018-12-27 19:30:28 | [$$] Sen. Johnny Isakson Called FBI on Behalf of MiMedx Group

2018-12-12 07:00:00 | Today's Research Reports on Trending Tickers: MiMedx Group and Tandem Diabetes Care

2018-12-11 19:25:44 | [$$] MiMedx Called on Two Lawmakers for Help Before Its Accounting Scandal

2018-12-05 19:27:32 | [$$] MiMedx to Shed Jobs as Part of Overhaul

2018-12-05 10:12:51 | [$$] Help Wanted, Get in on Ground Floor

2018-12-05 08:05:00 | MiMedx Announces Resignation Of Outside Auditor

2018-12-05 08:02:00 | MiMedx Announces Leadership Changes And Promotions

2018-12-05 08:00:00 | MiMedx Announces Organizational Realignment Program

2018-11-20 09:05:00 | 4 Healthcare Stocks You Should Get To Know Before 2019

2018-11-08 07:05:00 | Today's Research Reports on Trending Tickers: Tandem Diabetes Care and MiMedx

2018-11-07 17:57:00 | Jack Henry & Associates Set to Join S&P 500; EQT, Equitrans Midstream, MasTec to Join S&P MidCap 400; Superior Energy Services, United Natural Foods to Join S&P SmallCap 600

2018-11-07 14:16:36 | [$$] Nasdaq to Delist MiMedx Amid Financial Probe

2018-11-07 13:08:00 | Here's Why MiMedx Group Shares Are Imploding 30% Today

2018-11-07 12:24:56 | MDXG News: MiMedx Stock Plunges on Nasdaq Delisting Notice

2018-11-07 09:55:00 | MiMedx stock plunges after receiving delisting notice from Nasdaq

2018-11-07 08:02:00 | MiMedx Adopts Limited Duration Shareholder Rights Plan In Response To Delisting From Nasdaq

2018-11-07 08:00:00 | MiMedx Receives Nasdaq Delisting Notification

2018-11-06 12:29:00 | MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference

2018-10-31 13:26:00 | MiMedx to Present Clinical and Scientific Studies at SAWC Fall Meeting

2018-10-10 07:28:41 | MiMedx founder and former CEO Pete Petit prepares for battle

2018-10-05 05:30:10 | [$$] MiMedx Kept Cheaper Products Out of Its Offerings to VA Hospitals

2018-10-04 20:48:00 | Here's Why MiMedx Group, Inc. Gained 16.6% in September

2018-09-25 13:11:01 | How to Identify a Perfect Short Target

2018-09-25 08:30:00 | MiMedx Publishes Positive Results From Clinical Study Of Human Umbilical Cord For Diabetic Foot Ulcers

2018-09-21 15:36:53 | MiMedx Stock Shoots Higher After Earlier Drop

2018-09-21 08:00:00 | Today's Research Reports on Trending Tickers: MiMedx Group and Galectin Therapeutics

2018-09-21 07:26:13 | MiMedx says ex-CEO Parker Petit, other execs engaged in 'conduct detrimental to the business'

2018-09-20 22:00:00 | Kaskela Law LLC Announces Investigation of MiMedx Group, Inc. on Behalf of Current Stockholders - MDXG

2018-09-20 20:30:57 | [$$] Former MiMedx Executives to Lose Compensation

2018-09-20 17:51:36 | MiMedx Plans to Claw Back Pay From Ex-CEO and Other Bosses

2018-09-20 17:51:36 | MiMedx Ex-CEO Criticizes ‘Unfair’ Probe That Led to His Ouster

2018-09-20 17:15:00 | MiMedx Announces Nasdaq Listing Extension

2018-09-20 17:10:00 | Mimedx Provides Update on Previously Announced Senior Executive Separations

2018-09-10 12:44:00 | Here's Why MiMedx Group Inc. Rose 24.7% in August

2018-08-24 08:30:00 | MiMedx Announces Statistically Significant Results In New Multicenter Clinical Study Of Healing Of Diabetic Foot Ulcers Using EpiFix®

2018-08-16 16:33:00 | Why Dillard's, MiMedx Group, and Global Net Lease Slumped Today

2018-08-15 22:47:07 | [$$] Health Insurer Shuns Amniotic-Tissue Product From MiMedx

2018-08-15 17:15:00 | MiMedx Receives Additional Nasdaq Listing Notice Due to Late Form 10-Q

2018-08-15 13:30:00 | MiMedx Provides Additional Information and Context to Wall Street Journal Article

2018-08-14 20:42:51 | [$$] Insurer Stops Reimbursing for Some MiMedx Products

2018-08-14 17:00:00 | Yet Another Setback Caused MiMedx Group Shares to Tumble Today

2018-08-13 08:00:00 | MiMedx announces Nasdaq listing extension and Hearing Date

2018-08-09 10:00:00 | MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

2018-08-02 08:30:00 | MiMedx Announces Publication Of Phase 2B Clinical Trial Efficacy Data For Micronized dHACM In The Treatment Of Plantar Fasciitis In Foot & Ankle International

2018-08-01 11:00:00 | Schubert Jonckheer & Kolbe LLP Launches Investigation into Possible Breaches of Fiduciary Duty by MiMedx Group, Inc.'s Directors and Officers

2018-07-27 15:00:21 | Here's Why MiMedx Group Inc. Stock Is Falling Today

2018-07-26 19:20:34 | [$$] MiMedx Gets Delisting Notice From Nasdaq

2018-07-26 17:00:00 | MiMedx Announces Receipt of Nasdaq Letter

2018-07-23 12:18:23 | [$$] Highflying Medical Firm, a Help to Wounded Veterans, Falls to Earth